Justin J Yerbury

15PUBLICATIONS
41CO-AUTHORS
Proteomics and intermolecular interactions (excl. medical proteomics)Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 15, 2024
High-content analysis of proteostasis capacity in cellular models of amyotrophic lateral sclerosis (ALS).

Isabella A Lambert-Smith, Victoria K Shephard, Luke McAlary

|Jul 28, 2022
Cells Overexpressing ALS-Associated SOD1 Variants Are Differentially Susceptible to CuATSM-Associated Toxicity.

Mikayla L Brown, Luke McAlary, Jeremy S Lum

|Apr 28, 2022
P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons.

Rachael Bartlett, Diane Ly, Neil R Cashman

|May 19, 2021
Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives.

Gayathri R Ediriweera, Liyu Chen, Justin J Yerbury

|Jul 15, 2020
Neurodegenerative disease-associated protein aggregates are poor inducers of the heat shock response in neuronal cells.

Rebecca San Gil, Dezerae Cox, Luke McAlary

Pageof 3